(Q80297345)

PubMed publication ID

16985877

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985877%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Selective estrogen receptor modulators to prevent treatment-related osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

7 May 2020

1 reference

Matthew R Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

7 May 2020

publication date

1 January 2005

1 reference

PubMed publication ID

16985877

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985877%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

7 May 2020

volume

7 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

7 May 2020

page(s)

S30-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

Differential effects of androgens and estrogens on bone turnover in normal men.

7 May 2020

cites work

1 reference

12 December 2020

The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer

1 reference

12 December 2020

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

12 December 2020

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial

1 reference

12 December 2020

HIP FRACTURES IN MEN WITH PROSTATE CANCER TREATED WITH ORCHIECTOMY

1 reference

12 December 2020

The diagnostic value of bone scintigraphy in patients with low back pain

1 reference

12 December 2020

Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens

1 reference

12 December 2020

The diagnosis of osteoporosis

1 reference

12 December 2020

Osteoporosis after orchiectomy for prostate cancer

1 reference

12 December 2020

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

12 December 2020

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens

1 reference

12 December 2020

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis

1 reference

12 December 2020

1 reference

12 December 2020

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

1 reference

12 December 2020

1 reference

12 December 2020

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

1 reference

12 December 2020

Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma

1 reference

12 December 2020

The structural basis of bone fragility in men.

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

1 reference

12 December 2020

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer

1 reference

12 December 2020

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

1 reference

12 December 2020

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

1 reference

12 December 2020

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

12 December 2020

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

1 reference

12 December 2020

Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer

1 reference

12 December 2020

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy

1 reference

12 December 2020

Fracture risk following bilateral orchiectomy

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1550783&resulttype=core&format=json

7 May 2020

PubMed publication ID

16985877

1 reference